Vyome Holdings (HIND) Earnings Date & Reports

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HIND is expected to report earnings to rise 110.00% to -20 cents per share on November 24

Vyome Holdings HIND Stock Earnings Reports

Q3'26

Est.

$-0.21

Q2'26

Beat

by $0.09

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.08

The last earnings report on August 25 showed earnings per share of -10 cents, beating the estimate of -18 cents. With 12.72K shares outstanding, the current market capitalization sits at 14.46M.

View a ticker or compare two or three

HIND

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for HIND